Dental and medical supply company Henry Schein reported $3.2 billion in total net sales during the first quarter of 2025, according to a May 5 news release.
Here are nine more things to know about the company’s performance in the first quarter:
- Global dental distribution merchandise sales for the first quarter of 2025 were up 0.4% over the first quarter of 2024.
- Compared to the first quarter last year, global dental distribution equipment sales decreased 2.4% in the first quarter of 2025.
- Implant and biomaterial sales, as well as acquisition growth led to a 4.3% increase in global specialty product sales during the quarter compared to 2024 first quarter sales.
- Global technology sales, driven by dental practice management systems and cloud-based programs, increased 3.4%.
- The company recorded $110 million in GAAP net income and $143 million in non-GAAP income in the first quarter.
- Adjusted EBITDA for the first quarter of 2025 was $259 million, compared to $255 million in the first quarter of 2024.
- Henry Schein reported $25 million in restructuring costs during the first quarter.
- During the first quarter, Henry Schein repurchased about 2.3 million shares of its common stock for $161 million. The company has more than $700 million available and authorized for future stock repurchases.
- The company expects total sales growth for 2025 to increase between 2% and 4% over 2024.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place November 12–14 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
